Study Start Up Lead

Description

Talentmark is recruiting for a Country Study Start Up Lead to join a company in the Pharmaceutical industry, at their site based in Welwyn Garden City, on a contract basis for 6 months.

Salary:

Daily: £339 - £376.97 PAYE or £450 - £500 per day Umbrella.

Country Study Lead Role:

Drive and facilitate efficient study start-up processes to contribute to the delivery of clinical trials to patients.

Leading the country strategy for study start-up, driving efficiency, innovation, and collaboration with external stakeholders.

Overseeing start-up operations and ensuring timely and efficient site activation and regulatory compliance.

Engaging with government and institutional bodies to align on clinical trial policies and practices (e.g., with Ethics Boards, Health Authorities).Your Background:

Degree (MD, PhD, MA/MS, BA/BS) in life sciences or equivalent. Postgraduate degree or master’s degree highly desirable

Demonstrated experience in clinical trial start-up, regulatory submissions, and cross-functional collaboration

Strong experience with UK specific clinical start up systems including IRAS, CPMS & iCT and ARSAC

Strong understanding of ICH-GCP, EU CTR, and local regulatory environments

Experience managing vendor/CRO relationships

Experience management site relationships and leading leading site set up through to site activationCompany:

Our client is one of the world's premier innovative biopharmaceutical companies, discovering, developing and providing over 160 different medicines, vaccines and consumer healthcare products to help improve the lives of millions of people in the UK and around the world every year.

Location:

This role is based at our clients site in Welwyn Garden City, for 2 days a week, and there will be some site visits, and home working for the remainder of the week. xjnqpsq

Apply:

It is essential that applicants hold entitlement to work in the UK. Please quote job reference (phone number removed) in all correspondence.

Please note:

This role may be subject to a satisfactory basic Disclosure and Barring Service (DBS) check

Ad ID: 5418070113